Digest Network Come funziona
Network
/
Società
Ni
Non verificato

Niagen Bioscience, Inc

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteScienzaWeb e Social Network

50 comunicati stampa

Guarda tutti i comunicati
28/07/2026
Industria
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biological Aging
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
27/07/2026
Eventi
Web e Social Network
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
21/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
13/07/2026
Industria
Salute
Igiene alimentare
Vetrine/Shopping
Infanzia
Sanità
Farmaceutica
Biotecnologia
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
09/07/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Telefonia e Varie
Web e Social Network
Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
08/07/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Industria
Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
03/06/2026
Eventi
Web e Social Network
Biotecnologia
Scienza
Salute
Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
02/06/2026
Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
08/05/2026
Eventi
Biotecnologia
Salute
Scienza
Farmaceutica
Niagen Bioscience Announces Participation in Upcoming Investor Conferences
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0
06/05/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
Fonte
Niagen Bioscience, Inc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0